The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme

This study is ongoing, but not recruiting participants.
Information provided by Neopharm

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Glioblastoma Multiforme
2		Additional conditions recognized in this trial
			Glioblastoma
3		More general conditions related to this trial
			Astrocytoma
			Glioma
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms, Germ Cell and Embryonal
			Neoplasms, Glandular and Epithelial
			Neoplasms, Nerve Tissue
			Neoplasms, Neuroepithelial
			Neuroectodermal Tumors
4		Interventions listed in this trial
			IL13-PE38QQR
5		Additional drug interventions recognized in this trial
			Carmustine
6		More general drug interventions related to this trial
			Alkylating Agents
			Antineoplastic Agents
			Antineoplastic Agents, Alkylating
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Therapeutic Uses
7		Sponsors listed in this trial
			Neopharm